2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Restless leg syndrome in Neuro-Behcet’s and Behcet’s disease

M. Kuzu Kumcu, S. Erdoğan, M. Sorgun, C. Yücesan (Ankara, Turkey)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Restoring AADC enzyme synthesis in AADC deficiency: MRI-Guided Delivery of AAV2-hAADC Gene Therapy to the Midbrain

K. Bankiewicz, T. Pearson, A. Grijalvo-Perez, A. Viehoever, W. San Sebastian, J. Imamura-Ching, Y. Seo, P. Larson, N. Gupta (San Francisco, CA, USA)

Gene and Cell-Based Therapies · Les Muses Terrace, Level 3

1:45pm-3:15pm: Results of community pharmacist-led structured medication reviews in Parkinson’s Disease

N. Oonk, P. Oude Avenhuis, K. Movig, K. Koehorst-Ter Huurne, WH. Nijmeijer, M. van Kesteren-Biegstraaten, J. Vd Palen, L. Dorresteijn (Enschede, Netherlands)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Reverse phenotyping of a 3.3Mb loss of 8p11.21p11.1, including SLC20A2, lead to a diagnosis of primary familial brain calcification

A. Kievit, L. Zutven, A. Boon (Rotterdam, Netherlands)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Reviewing the clinical and mutational spectrum of SLC20A2, PDGFB, PDGFRB, XPR1 and MYORG mutations in Primary Familial Brain Calcification (PFBC) for MDSGene

A. Balck, S. Schaake, J. Margolesky, A. Domingo, C. Klein, A. Westenberger (Lubeck, Germany)

Genetics · Les Muses Terrace, Level 3

1:45pm-3:15pm: Rhythmic disorders in idiopathic RBD: a potential new marker for future PD?

V. Cochen Decock, D. Verbizier, C. Geny, S. Dalla Bella (Montpellier, France)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: RimbotulinumtoxinB in the treatment of adult sialorrhea

S. Isaacson, W. Ondo, M. Lew, K. Dashtipour, D. Chary, T. Clinch, F. Pagan (Boca Raton, FL, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Risk Thresholds of Levodopa Dose for Dyskinesia in Chinese Patients with Parkinson’s Disease: A Pilot Study

GL. Liu, T. Feng (Beijing, China)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Rivastigmine for visual hallucinations in Parkinson’s disease

T. Mierlo, E. Foncke, R. Bie (Amsterdam, Netherlands)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study

S. Taib, F. Ory-Magne, C. Brefel-Courbon, Y. Moreau, C. Thalamas, C. Arbus, M. Simonetta-Moreau (Toulouse, France)

Functional (Psychogenic) Movement Disorders · Les Muses Terrace, Level 3